nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Blacked-out (not amnesia)—Irinotecan—colon cancer	0.106	0.115	CcSEcCtD
Hydroxychloroquine—Optic atrophy—Vincristine—colon cancer	0.0407	0.0444	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Capecitabine—colon cancer	0.0153	0.0166	CcSEcCtD
Hydroxychloroquine—Cardiomyopathy—Fluorouracil—colon cancer	0.0142	0.0155	CcSEcCtD
Hydroxychloroquine—Abdominal cramps—Vincristine—colon cancer	0.0116	0.0126	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Vincristine—colon cancer	0.0116	0.0126	CcSEcCtD
Hydroxychloroquine—Reaction gastrointestinal—Methotrexate—colon cancer	0.0114	0.0124	CcSEcCtD
Hydroxychloroquine—Hypokinesia—Irinotecan—colon cancer	0.0113	0.0123	CcSEcCtD
Hydroxychloroquine—Abdominal cramps—Irinotecan—colon cancer	0.0113	0.0123	CcSEcCtD
Hydroxychloroquine—Paralysis—Vincristine—colon cancer	0.0112	0.0123	CcSEcCtD
Hydroxychloroquine—Nystagmus—Vincristine—colon cancer	0.0109	0.0119	CcSEcCtD
Hydroxychloroquine—Retinal disorder—Methotrexate—colon cancer	0.0106	0.0116	CcSEcCtD
Hydroxychloroquine—Nystagmus—Fluorouracil—colon cancer	0.0102	0.0111	CcSEcCtD
Hydroxychloroquine—Cardiomyopathy—Capecitabine—colon cancer	0.00995	0.0109	CcSEcCtD
Hydroxychloroquine—Leukoderma—Methotrexate—colon cancer	0.00892	0.00972	CcSEcCtD
Hydroxychloroquine—Visual acuity reduced—Capecitabine—colon cancer	0.00856	0.00934	CcSEcCtD
Hydroxychloroquine—Appetite absent—Methotrexate—colon cancer	0.00762	0.00831	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Capecitabine—colon cancer	0.00754	0.00823	CcSEcCtD
Hydroxychloroquine—Throat sore—Capecitabine—colon cancer	0.00706	0.0077	CcSEcCtD
Hydroxychloroquine—Oropharyngeal discomfort—Capecitabine—colon cancer	0.007	0.00764	CcSEcCtD
Hydroxychloroquine—Photophobia—Fluorouracil—colon cancer	0.00684	0.00746	CcSEcCtD
Hydroxychloroquine—Quinacrine—ABCB1—colon cancer	0.00644	0.53	CrCbGaD
Hydroxychloroquine—Deafness—Vincristine—colon cancer	0.00634	0.00691	CcSEcCtD
Hydroxychloroquine—Eruption—Methotrexate—colon cancer	0.00616	0.00672	CcSEcCtD
Hydroxychloroquine—Psoriasis—Methotrexate—colon cancer	0.00603	0.00658	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Fluorouracil—colon cancer	0.00602	0.00657	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Irinotecan—colon cancer	0.00585	0.00638	CcSEcCtD
Hydroxychloroquine—Contusion—Capecitabine—colon cancer	0.00584	0.00636	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Irinotecan—colon cancer	0.00583	0.00636	CcSEcCtD
Hydroxychloroquine—Chloroquine—ABCB1—colon cancer	0.00571	0.47	CrCbGaD
Hydroxychloroquine—Skin discolouration—Capecitabine—colon cancer	0.00564	0.00615	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Methotrexate—colon cancer	0.00562	0.00612	CcSEcCtD
Hydroxychloroquine—Oropharyngeal pain—Capecitabine—colon cancer	0.0056	0.00611	CcSEcCtD
Hydroxychloroquine—Liver disorder—Methotrexate—colon cancer	0.00556	0.00606	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Fluorouracil—colon cancer	0.00553	0.00604	CcSEcCtD
Hydroxychloroquine—Paralysis—Methotrexate—colon cancer	0.00546	0.00595	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Fluorouracil—colon cancer	0.00542	0.00591	CcSEcCtD
Hydroxychloroquine—Hearing impaired—Capecitabine—colon cancer	0.00535	0.00583	CcSEcCtD
Hydroxychloroquine—Ataxia—Vincristine—colon cancer	0.00533	0.00582	CcSEcCtD
Hydroxychloroquine—Irritability—Fluorouracil—colon cancer	0.00505	0.00551	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Vincristine—colon cancer	0.005	0.00545	CcSEcCtD
Hydroxychloroquine—Ataxia—Fluorouracil—colon cancer	0.00497	0.00542	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Fluorouracil—colon cancer	0.00467	0.00509	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Vincristine—colon cancer	0.00465	0.00508	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Fluorouracil—colon cancer	0.00453	0.00494	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Vincristine—colon cancer	0.00447	0.00488	CcSEcCtD
Hydroxychloroquine—Weight decreased—Vincristine—colon cancer	0.00443	0.00484	CcSEcCtD
Hydroxychloroquine—Depression—Vincristine—colon cancer	0.00436	0.00475	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Fluorouracil—colon cancer	0.00434	0.00473	CcSEcCtD
Hydroxychloroquine—Weight decreased—Irinotecan—colon cancer	0.00432	0.00471	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Capecitabine—colon cancer	0.00423	0.00461	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Capecitabine—colon cancer	0.00421	0.00459	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Methotrexate—colon cancer	0.0042	0.00458	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00417	0.00455	CcSEcCtD
Hydroxychloroquine—Deafness—Capecitabine—colon cancer	0.00413	0.00451	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Capecitabine—colon cancer	0.00392	0.00427	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Capecitabine—colon cancer	0.00387	0.00422	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Irinotecan—colon cancer	0.00384	0.00419	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Irinotecan—colon cancer	0.00382	0.00417	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Fluorouracil—colon cancer	0.0038	0.00415	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Capecitabine—colon cancer	0.00379	0.00413	CcSEcCtD
Hydroxychloroquine—Visual impairment—Irinotecan—colon cancer	0.00368	0.00402	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Fluorouracil—colon cancer	0.00368	0.00401	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Fluorouracil—colon cancer	0.00366	0.00399	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Methotrexate—colon cancer	0.00356	0.00388	CcSEcCtD
Hydroxychloroquine—Irritability—Capecitabine—colon cancer	0.00353	0.00385	CcSEcCtD
Hydroxychloroquine—Mood swings—Capecitabine—colon cancer	0.0035	0.00382	CcSEcCtD
Hydroxychloroquine—Ataxia—Capecitabine—colon cancer	0.00348	0.00379	CcSEcCtD
Hydroxychloroquine—Alopecia—Vincristine—colon cancer	0.00347	0.00378	CcSEcCtD
Hydroxychloroquine—Mental disorder—Vincristine—colon cancer	0.00344	0.00375	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Capecitabine—colon cancer	0.00341	0.00372	CcSEcCtD
Hydroxychloroquine—Alopecia—Irinotecan—colon cancer	0.00338	0.00368	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Capecitabine—colon cancer	0.00338	0.00368	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00333	0.00363	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Capecitabine—colon cancer	0.00326	0.00356	CcSEcCtD
Hydroxychloroquine—Alopecia—Fluorouracil—colon cancer	0.00323	0.00353	CcSEcCtD
Hydroxychloroquine—Anaemia—Vincristine—colon cancer	0.00316	0.00344	CcSEcCtD
Hydroxychloroquine—Bronchospasm—Capecitabine—colon cancer	0.00314	0.00343	CcSEcCtD
Hydroxychloroquine—Agitation—Vincristine—colon cancer	0.00314	0.00342	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Methotrexate—colon cancer	0.00313	0.00342	CcSEcCtD
Hydroxychloroquine—Anaemia—Irinotecan—colon cancer	0.00307	0.00335	CcSEcCtD
Hydroxychloroquine—Vertigo—Vincristine—colon cancer	0.00307	0.00335	CcSEcCtD
Hydroxychloroquine—Leukopenia—Vincristine—colon cancer	0.00306	0.00333	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Capecitabine—colon cancer	0.00303	0.00331	CcSEcCtD
Hydroxychloroquine—Vision blurred—Fluorouracil—colon cancer	0.003	0.00327	CcSEcCtD
Hydroxychloroquine—Vertigo—Irinotecan—colon cancer	0.00299	0.00326	CcSEcCtD
Hydroxychloroquine—Leukopenia—Irinotecan—colon cancer	0.00298	0.00325	CcSEcCtD
Hydroxychloroquine—Convulsion—Vincristine—colon cancer	0.00296	0.00323	CcSEcCtD
Hydroxychloroquine—Anaemia—Fluorouracil—colon cancer	0.00294	0.00321	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Irinotecan—colon cancer	0.00292	0.00319	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Methotrexate—colon cancer	0.00292	0.00318	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Capecitabine—colon cancer	0.00292	0.00318	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Methotrexate—colon cancer	0.0029	0.00317	CcSEcCtD
Hydroxychloroquine—Weight decreased—Capecitabine—colon cancer	0.00289	0.00315	CcSEcCtD
Hydroxychloroquine—Leukopenia—Fluorouracil—colon cancer	0.00285	0.00311	CcSEcCtD
Hydroxychloroquine—Depression—Capecitabine—colon cancer	0.00284	0.0031	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00282	0.00308	CcSEcCtD
Hydroxychloroquine—Oedema—Vincristine—colon cancer	0.00279	0.00304	CcSEcCtD
Hydroxychloroquine—Convulsion—Fluorouracil—colon cancer	0.00276	0.00301	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Vincristine—colon cancer	0.00273	0.00298	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Vincristine—colon cancer	0.00273	0.00298	CcSEcCtD
Hydroxychloroquine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00273	0.0385	CbGpPWpGaD
Hydroxychloroquine—Oedema—Irinotecan—colon cancer	0.00271	0.00296	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Irinotecan—colon cancer	0.00266	0.0029	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Capecitabine—colon cancer	0.00266	0.0029	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Irinotecan—colon cancer	0.00266	0.0029	CcSEcCtD
Hydroxychloroquine—Anorexia—Vincristine—colon cancer	0.00266	0.0029	CcSEcCtD
Hydroxychloroquine—Irritability—Methotrexate—colon cancer	0.00263	0.00286	CcSEcCtD
Hydroxychloroquine—Mood swings—Methotrexate—colon cancer	0.00261	0.00284	CcSEcCtD
Hydroxychloroquine—Oedema—Fluorouracil—colon cancer	0.0026	0.00284	CcSEcCtD
Hydroxychloroquine—Anorexia—Irinotecan—colon cancer	0.00259	0.00282	CcSEcCtD
Hydroxychloroquine—Ataxia—Methotrexate—colon cancer	0.00259	0.00282	CcSEcCtD
Hydroxychloroquine—TLR9—PI3K Cascade—FGFR3—colon cancer	0.00257	0.0362	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Capecitabine—colon cancer	0.00257	0.0028	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Capecitabine—colon cancer	0.00256	0.00279	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Fluorouracil—colon cancer	0.00255	0.00278	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Fluorouracil—colon cancer	0.00255	0.00278	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Methotrexate—colon cancer	0.00254	0.00277	CcSEcCtD
Hydroxychloroquine—Anorexia—Fluorouracil—colon cancer	0.00248	0.0027	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00248	0.0027	CcSEcCtD
Hydroxychloroquine—Visual impairment—Capecitabine—colon cancer	0.00246	0.00269	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Vincristine—colon cancer	0.00242	0.00264	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Capecitabine—colon cancer	0.00242	0.00264	CcSEcCtD
Hydroxychloroquine—Somnolence—Irinotecan—colon cancer	0.00241	0.00263	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Vincristine—colon cancer	0.00241	0.00262	CcSEcCtD
Hydroxychloroquine—Fatigue—Vincristine—colon cancer	0.0024	0.00262	CcSEcCtD
Hydroxychloroquine—Eye disorder—Capecitabine—colon cancer	0.00239	0.00261	CcSEcCtD
Hydroxychloroquine—Tinnitus—Capecitabine—colon cancer	0.00238	0.0026	CcSEcCtD
Hydroxychloroquine—Pain—Vincristine—colon cancer	0.00238	0.0026	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Irinotecan—colon cancer	0.00236	0.00257	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Methotrexate—colon cancer	0.00235	0.00257	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00234	0.00256	CcSEcCtD
Hydroxychloroquine—Fatigue—Irinotecan—colon cancer	0.00234	0.00255	CcSEcCtD
Hydroxychloroquine—Pain—Irinotecan—colon cancer	0.00232	0.00253	CcSEcCtD
Hydroxychloroquine—Somnolence—Fluorouracil—colon cancer	0.00231	0.00252	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Vincristine—colon cancer	0.00228	0.00249	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Fluorouracil—colon cancer	0.00226	0.00246	CcSEcCtD
Hydroxychloroquine—Alopecia—Capecitabine—colon cancer	0.00226	0.00246	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Methotrexate—colon cancer	0.00226	0.00246	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00224	0.00245	CcSEcCtD
Hydroxychloroquine—Mental disorder—Capecitabine—colon cancer	0.00224	0.00244	CcSEcCtD
Hydroxychloroquine—Malnutrition—Capecitabine—colon cancer	0.00223	0.00243	CcSEcCtD
Hydroxychloroquine—Pain—Fluorouracil—colon cancer	0.00222	0.00242	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Irinotecan—colon cancer	0.00222	0.00242	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Vincristine—colon cancer	0.0022	0.0024	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Vincristine—colon cancer	0.0022	0.0024	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—colon cancer	0.00217	0.00237	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—FGFR3—colon cancer	0.00215	0.0303	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Irinotecan—colon cancer	0.00215	0.00234	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Irinotecan—colon cancer	0.00215	0.00234	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—colon cancer	0.00212	0.00231	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—colon cancer	0.00211	0.00231	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.0021	0.00229	CcSEcCtD
Hydroxychloroquine—Vision blurred—Capecitabine—colon cancer	0.0021	0.00229	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—FGFR3—colon cancer	0.00209	0.0295	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—FGFR3—colon cancer	0.00207	0.0292	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Fluorouracil—colon cancer	0.00207	0.00225	CcSEcCtD
Hydroxychloroquine—Anaemia—Capecitabine—colon cancer	0.00206	0.00224	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Fluorouracil—colon cancer	0.00206	0.00224	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Vincristine—colon cancer	0.00205	0.00224	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—FGFR3—colon cancer	0.00202	0.0285	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—FGFR3—colon cancer	0.00202	0.0285	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Capecitabine—colon cancer	0.002	0.00218	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Irinotecan—colon cancer	0.002	0.00218	CcSEcCtD
Hydroxychloroquine—Asthenia—Vincristine—colon cancer	0.002	0.00218	CcSEcCtD
Hydroxychloroquine—Leukopenia—Capecitabine—colon cancer	0.00199	0.00217	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—colon cancer	0.00198	0.00216	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Capecitabine—colon cancer	0.00196	0.00213	CcSEcCtD
Hydroxychloroquine—Asthenia—Irinotecan—colon cancer	0.00195	0.00212	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Fluorouracil—colon cancer	0.00192	0.00209	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methotrexate—colon cancer	0.00191	0.00209	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Vincristine—colon cancer	0.00191	0.00208	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.00191	0.0269	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Methotrexate—colon cancer	0.0019	0.00208	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00188	0.00205	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Irinotecan—colon cancer	0.00186	0.00203	CcSEcCtD
Hydroxychloroquine—Dizziness—Vincristine—colon cancer	0.00184	0.00201	CcSEcCtD
Hydroxychloroquine—Pruritus—Fluorouracil—colon cancer	0.00184	0.00201	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—colon cancer	0.00183	0.002	CcSEcCtD
Hydroxychloroquine—Oedema—Capecitabine—colon cancer	0.00182	0.00198	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—colon cancer	0.0018	0.00196	CcSEcCtD
Hydroxychloroquine—Dizziness—Irinotecan—colon cancer	0.00179	0.00196	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Capecitabine—colon cancer	0.00178	0.00194	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—colon cancer	0.00178	0.00194	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Fluorouracil—colon cancer	0.00178	0.00194	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Capecitabine—colon cancer	0.00178	0.00194	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—colon cancer	0.00177	0.00194	CcSEcCtD
Hydroxychloroquine—Vomiting—Vincristine—colon cancer	0.00177	0.00193	CcSEcCtD
Hydroxychloroquine—Skin disorder—Capecitabine—colon cancer	0.00176	0.00192	CcSEcCtD
Hydroxychloroquine—Rash—Vincristine—colon cancer	0.00176	0.00192	CcSEcCtD
Hydroxychloroquine—Dermatitis—Vincristine—colon cancer	0.00176	0.00191	CcSEcCtD
Hydroxychloroquine—Headache—Vincristine—colon cancer	0.00175	0.0019	CcSEcCtD
Hydroxychloroquine—Anorexia—Capecitabine—colon cancer	0.00173	0.00189	CcSEcCtD
Hydroxychloroquine—Vomiting—Irinotecan—colon cancer	0.00173	0.00188	CcSEcCtD
Hydroxychloroquine—Dizziness—Fluorouracil—colon cancer	0.00172	0.00187	CcSEcCtD
Hydroxychloroquine—Rash—Irinotecan—colon cancer	0.00171	0.00187	CcSEcCtD
Hydroxychloroquine—Dermatitis—Irinotecan—colon cancer	0.00171	0.00186	CcSEcCtD
Hydroxychloroquine—Headache—Irinotecan—colon cancer	0.0017	0.00185	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—colon cancer	0.00168	0.00183	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—FGFR3—colon cancer	0.00168	0.0236	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Methotrexate—colon cancer	0.00167	0.00182	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—colon cancer	0.00166	0.00181	CcSEcCtD
Hydroxychloroquine—Nausea—Vincristine—colon cancer	0.00166	0.00181	CcSEcCtD
Hydroxychloroquine—Vomiting—Fluorouracil—colon cancer	0.00165	0.0018	CcSEcCtD
Hydroxychloroquine—Rash—Fluorouracil—colon cancer	0.00164	0.00179	CcSEcCtD
Hydroxychloroquine—Dermatitis—Fluorouracil—colon cancer	0.00164	0.00179	CcSEcCtD
Hydroxychloroquine—Headache—Fluorouracil—colon cancer	0.00163	0.00178	CcSEcCtD
Hydroxychloroquine—Nausea—Irinotecan—colon cancer	0.00161	0.00176	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Capecitabine—colon cancer	0.00158	0.00172	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00157	0.00171	CcSEcCtD
Hydroxychloroquine—Fatigue—Capecitabine—colon cancer	0.00157	0.00171	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—colon cancer	0.00156	0.0017	CcSEcCtD
Hydroxychloroquine—Pain—Capecitabine—colon cancer	0.00155	0.00169	CcSEcCtD
Hydroxychloroquine—Nausea—Fluorouracil—colon cancer	0.00154	0.00168	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—colon cancer	0.00153	0.00167	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—colon cancer	0.00149	0.00162	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Capecitabine—colon cancer	0.00149	0.00162	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—colon cancer	0.00148	0.00162	CcSEcCtD
Hydroxychloroquine—Urticaria—Capecitabine—colon cancer	0.00144	0.00157	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Capecitabine—colon cancer	0.00144	0.00157	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Capecitabine—colon cancer	0.00144	0.00157	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—colon cancer	0.00144	0.00157	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.0014	0.00153	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Capecitabine—colon cancer	0.00134	0.00146	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—colon cancer	0.00133	0.00145	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—colon cancer	0.00132	0.00144	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—colon cancer	0.00131	0.00143	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—BCL10—colon cancer	0.00131	0.0185	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Capecitabine—colon cancer	0.0013	0.00142	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—colon cancer	0.00129	0.00141	CcSEcCtD
Hydroxychloroquine—Pruritus—Capecitabine—colon cancer	0.00129	0.0014	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Capecitabine—colon cancer	0.00124	0.00136	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—colon cancer	0.0012	0.00131	CcSEcCtD
Hydroxychloroquine—Dizziness—Capecitabine—colon cancer	0.0012	0.00131	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Methotrexate—colon cancer	0.00118	0.00128	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00117	0.00127	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—NRAS—colon cancer	0.00117	0.0164	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Methotrexate—colon cancer	0.00117	0.00127	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—colon cancer	0.00116	0.00126	CcSEcCtD
Hydroxychloroquine—Vomiting—Capecitabine—colon cancer	0.00116	0.00126	CcSEcCtD
Hydroxychloroquine—Rash—Capecitabine—colon cancer	0.00115	0.00125	CcSEcCtD
Hydroxychloroquine—Dermatitis—Capecitabine—colon cancer	0.00114	0.00125	CcSEcCtD
Hydroxychloroquine—Headache—Capecitabine—colon cancer	0.00114	0.00124	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—NRAS—colon cancer	0.00113	0.016	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—NRAS—colon cancer	0.00112	0.0158	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—colon cancer	0.00111	0.00121	CcSEcCtD
Hydroxychloroquine—TLR9—PI3K Cascade—PIK3CA—colon cancer	0.0011	0.0155	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—NRAS—colon cancer	0.00109	0.0154	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—NRAS—colon cancer	0.00109	0.0154	CbGpPWpGaD
Hydroxychloroquine—Nausea—Capecitabine—colon cancer	0.00108	0.00118	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—colon cancer	0.00107	0.00117	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—colon cancer	0.00107	0.00117	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—colon cancer	0.00107	0.00117	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—BCL10—colon cancer	0.00104	0.0146	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—colon cancer	0.00101	0.0142	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—colon cancer	0.001	0.0142	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Methotrexate—colon cancer	0.000996	0.00109	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—colon cancer	0.000976	0.0138	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Methotrexate—colon cancer	0.00097	0.00106	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—colon cancer	0.000967	0.0136	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Methotrexate—colon cancer	0.000957	0.00104	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—colon cancer	0.000942	0.0133	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—colon cancer	0.000942	0.0133	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Methotrexate—colon cancer	0.000925	0.00101	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—colon cancer	0.000922	0.013	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—NRAS—colon cancer	0.000909	0.0128	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—colon cancer	0.000897	0.0126	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—DLC1—colon cancer	0.000897	0.0126	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Methotrexate—colon cancer	0.000894	0.000975	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—colon cancer	0.000889	0.0125	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000875	0.0123	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—colon cancer	0.000866	0.0122	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—colon cancer	0.000866	0.0122	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Methotrexate—colon cancer	0.00086	0.000938	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—HRAS—colon cancer	0.000853	0.012	CbGpPWpGaD
Hydroxychloroquine—Rash—Methotrexate—colon cancer	0.000853	0.00093	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—colon cancer	0.000852	0.000929	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—colon cancer	0.000847	0.000924	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—LGR5—colon cancer	0.000843	0.0119	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—HRAS—colon cancer	0.00083	0.0117	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—colon cancer	0.000824	0.0116	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—colon cancer	0.000822	0.0116	CbGpPWpGaD
Hydroxychloroquine—Nausea—Methotrexate—colon cancer	0.000803	0.000876	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—HRAS—colon cancer	0.000801	0.0113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—HRAS—colon cancer	0.000801	0.0113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—colon cancer	0.000797	0.0112	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—colon cancer	0.000787	0.0111	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—colon cancer	0.000783	0.011	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BCL10—colon cancer	0.000764	0.0108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—colon cancer	0.000719	0.0101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—HRAS—colon cancer	0.000665	0.00938	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—colon cancer	0.000651	0.00918	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	0.000643	0.00907	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—colon cancer	0.000622	0.00877	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—BCL2L1—colon cancer	0.000615	0.00867	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AXIN2—colon cancer	0.000606	0.00854	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL10—colon cancer	0.000604	0.00851	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—FGFR3—colon cancer	0.000588	0.00829	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	0.000508	0.00717	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—BCL2L1—colon cancer	0.000486	0.00685	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—FGFR3—colon cancer	0.000465	0.00655	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD8A—colon cancer	0.000419	0.0059	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CTNNB1—colon cancer	0.000367	0.00517	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CDKN1A—colon cancer	0.000358	0.00505	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BCL2L1—colon cancer	0.000358	0.00505	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FGFR3—colon cancer	0.000342	0.00483	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EP300—colon cancer	0.000341	0.0048	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—SRC—colon cancer	0.000331	0.00467	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD8A—colon cancer	0.000331	0.00466	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NRAS—colon cancer	0.000319	0.00449	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—colon cancer	0.00029	0.00409	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—colon cancer	0.00029	0.00409	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDH1—colon cancer	0.000289	0.00408	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1A—colon cancer	0.000283	0.00399	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2L1—colon cancer	0.000283	0.00399	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—colon cancer	0.000274	0.00387	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FGFR3—colon cancer	0.000271	0.00382	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EP300—colon cancer	0.000269	0.0038	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—SRC—colon cancer	0.000262	0.00369	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—colon cancer	0.000252	0.00355	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NRAS—colon cancer	0.000252	0.00355	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA7—colon cancer	0.00025	0.00353	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—colon cancer	0.000233	0.00329	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—colon cancer	0.00023	0.00324	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—colon cancer	0.000229	0.00322	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—colon cancer	0.000217	0.00306	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—colon cancer	0.000214	0.00301	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1A—colon cancer	0.000209	0.00294	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—colon cancer	0.000206	0.0029	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—colon cancer	0.000199	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EP300—colon cancer	0.000198	0.0028	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—SRC—colon cancer	0.000193	0.00272	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRAS—colon cancer	0.000186	0.00262	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—colon cancer	0.000184	0.0026	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR3—colon cancer	0.000175	0.00247	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—colon cancer	0.000169	0.00238	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—colon cancer	0.000169	0.00238	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1A—colon cancer	0.000165	0.00232	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—colon cancer	0.000163	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APC—colon cancer	0.000161	0.00226	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—colon cancer	0.00016	0.00225	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EP300—colon cancer	0.000157	0.00221	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SRC—colon cancer	0.000153	0.00215	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ODC1—colon cancer	0.000152	0.00214	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CHST5—colon cancer	0.000152	0.00214	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BRAF—colon cancer	0.000151	0.00213	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—colon cancer	0.000147	0.00207	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRAS—colon cancer	0.000147	0.00207	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—colon cancer	0.000136	0.00192	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—colon cancer	0.000134	0.00189	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—colon cancer	0.000126	0.00178	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—colon cancer	0.00012	0.00169	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—colon cancer	0.000116	0.00164	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—colon cancer	0.000113	0.0016	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—colon cancer	0.00011	0.00155	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—colon cancer	0.000109	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—colon cancer	0.000107	0.00151	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1A—colon cancer	0.000107	0.0015	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EP300—colon cancer	0.000101	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SRC—colon cancer	9.86e-05	0.00139	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—colon cancer	9.61e-05	0.00135	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRAS—colon cancer	9.49e-05	0.00134	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—colon cancer	9.48e-05	0.00134	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—colon cancer	8.84e-05	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—colon cancer	8.82e-05	0.00124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—colon cancer	8.64e-05	0.00122	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—colon cancer	8.17e-05	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—colon cancer	7.5e-05	0.00106	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—colon cancer	7.26e-05	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—colon cancer	6.94e-05	0.000979	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—colon cancer	6.13e-05	0.000864	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCB1—colon cancer	4.01e-05	0.000565	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TYMS—colon cancer	3.94e-05	0.000555	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARG—colon cancer	2.79e-05	0.000393	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—colon cancer	2.19e-05	0.000309	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—EP300—colon cancer	1.82e-05	0.000257	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.35e-05	0.00019	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—colon cancer	1.1e-05	0.000155	CbGpPWpGaD
